- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Baumann Skin Type Indicator in United Kingdom
Total 3321 results
-
Cancer Research UKActive, not recruitinga. Colorectal Cancer | b. High Grade Serous Ovarian Cancer | c. Non Small-cell Lung Cancer (Squamous Cell Variant) | d. Squamous Carcinoma of the Oesophagus | e. Squamous Carcinoma of the Head and Neck (HPV Negative) | f. Urothelial Cancer | g. Breast Cancer (Triple Negative Type) | h. Pancreatic...United Kingdom
-
Cancer Research UKUCB Biopharma SRLNot yet recruitingUterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Carcinoma, Renal Cell (Clear Cell Only) | Stomach Neoplasms...United Kingdom
-
GenmabTerminatedRenal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Urothelial CancerUnited States, United Kingdom, Spain
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingSkin Cancer | Melanoma (Skin) | Skin Carcinoma | Skin MelanomaUnited States
-
Nouscom SRLActive, not recruitingMelanoma (Skin) | Non-Small-Cell Lung CarcinomaBelgium, Spain, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States
-
AmgenCompletedPsoriasis | Plaque-type PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompleted3rd Line GISTItaly, Belgium, Spain, Netherlands, Germany, United Kingdom, France, United States
-
LYSOGENEActive, not recruitingMucopolysaccharidosis Type IIIAGermany, United States, United Kingdom, France, Netherlands
-
Orchard TherapeuticsRecruitingMPS-IH (Hurler Syndrome)Netherlands, United States, Italy, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Belgium, Germany, Argentina, Australia, France, Israel, Netherlands, Switzerland, United States, United Kingdom, Norway
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Eastern Virginia Medical SchoolNational Cancer Institute (NCI); National Institute of General Medical Sciences...UnknownMelanoma (Skin) | Non-melanomatous Skin CancerUnited States
-
Massachusetts General HospitalEnrolling by invitationSkin Lesion | Pigmented Lesions | Pigmented Skin Lesion | Pigmented MolesUnited States
-
Blueprint Medicines CorporationAnalysis Group, Inc.CompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematological NeoplasmUnited States, Austria, Germany, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States, Estonia, Japan, Latvia, Canada, Iceland
-
Cancer Research Campaign Clinical Trials CentreCompletedLymphoma | Testicular Germ Cell Tumor | Breast Cancer | Small Intestine Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Extragonadal Germ Cell TumorUnited Kingdom
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, Belgium, Germany, Italy, United Kingdom, Netherlands
-
Eisai LimitedCompletedOvarian Cancer | Triple Negative Breast Cancer | Malignant Solid Tumour | Advanced Melanoma | B-cell Malignancy, Low-gradeUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin MelanomaUnited States
-
NuCana plcRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Neoplasm Malignant | Pleural... and other conditionsUnited Kingdom
-
European Organisation for Research and Treatment...Active, not recruitingStage IV Melanoma | Unresectable Stage III MelanomaFrance, Denmark, Spain, Finland, Italy, Germany, Poland, United Kingdom, Netherlands
-
University of Alabama at BirminghamAmgenCompletedMelanoma | Psoriasis | Non-melanoma Skin CancerUnited States
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | MPS III BUnited States, Taiwan, Spain, Colombia, Germany, United Kingdom, Turkey
-
Ultragenyx Pharmaceutical IncMereo BioPharmaCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta, Type IUnited States, Canada, Denmark, France, United Kingdom
-
Children's Cancer and Leukaemia GroupCompletedSarcomaUnited Kingdom, Ireland
-
Center for Biomedical Research, Inc.RecruitingSkin Cancer | Squamous Cell Carcinoma | Squamous Cell Cancer | Non-melanoma Skin CancerUnited States
-
Vicept Therapeutics, Inc.AccentureCompletedErythematous (Type One) RosaceaUnited States
-
National Cancer Institute (NCI)TerminatedMelanoma | Skin CancerUnited States
-
University of PennsylvaniaNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedMelanoma | Skin CancerUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Joyce TengStanford UniversityNot yet recruiting
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Canada
-
Dana-Farber Cancer InstituteWorld Cancer Research Fund InternationalNot yet recruitingSkin Cancer | Melanoma (Skin) | Advanced MelanomaUnited States
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, Japan, France, Norway, Israel, Iceland
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedMelanoma (Skin) | Non-melanomatous Skin CancerUnited States
-
Novartis PharmaceuticalsCompleted3rd Line GISTFrance, United Kingdom, Belgium, Canada, Spain, Netherlands, Japan, United States
-
University of UtahGeorgetown University; West Virginia UniversityRecruiting
-
Roswell Park Cancer InstituteCompletedStage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterSchering-PloughCompletedMelanoma | Cancer | Skin CancerUnited States
-
National Cancer Institute (NCI)TerminatedSkin Cancer | Metastatic MelanomaUnited States
-
Renee CattellNot yet recruitingSkin Cancer | Basal Cell Carcinoma | Squamous Cell CarcinomaUnited States
-
Massachusetts General HospitalUnknownCarcinoma, Squamous Cell | Carcinoma, Basal CellUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH); University of RochesterCompletedMelanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-Malignant Skin DisordersUnited States
-
Wright State PhysiciansCompletedAllergic Contact DermatitisUnited States
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI)Completed